Tacrolimus Capsule, Gelatin Coated
Product Images NDC 43817-422

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 43817-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Panacea Biotec Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image000006

Image000006
Packaging label for Tacrolimus Capsules USP 5 mg, gelatin-coated oral capsules. The label shows packaging for 100 capsules, manufactured by Panacea Biotec Limited and distributed by Bionpharma Inc. The label features storage instructions, a barcode, and lists inactive ingredients including hypromellose, anhydrous lactose, croscarmellose sodium, and magnesium stearate in a hard gelatin capsule.*
FDA Label Image

Image00001

Image00001
Tacrolimus Capsules USP 0.5 mg gelatin coated oral capsules in a 100-count package. The label shows the drug's NDC code 43817-421-01 and states it is for prescription use only. Manufactured by Panacea Biotec Pharma Limited and distributed by Bionpharma Inc. Storage and dispensing instructions are also visible.*
FDA Label Image

Image00002

Image00002
Box packaging label for Tacrolimus Capsules USP, 0.5 mg, gelatin coated oral capsules. The package contains 100 capsules and is labeled for prescription use only. Manufactured by Panacea Biotec Limited, India, and distributed by Bionpharma Inc., USA. Storage instructions and inactive ingredients are provided, along with a barcode and manufacturing license number.*
FDA Label Image

Image00003

Image00003
Label for Tacrolimus Capsules USP 1 mg, gelatin-coated oral capsules, packaged in a container holding 100 capsules. The label includes storage instructions, dispensing guidance, manufacturer Panacea Biotec Pharma Limited in India, and distributor Bionpharma Inc. in New Jersey, USA. It also displays the NDC 43817-422-01 and space for lot number and expiration date.*
FDA Label Image

Image00004

Image00004
Packaging label for Tacrolimus Capsules USP, 1 mg, gelatin coated oral capsules. The label indicates a package size of 100 capsules. Manufactured by Panacea Biotec Pharma Limited, India, and distributed by Bionpharma Inc., Princeton, NJ, USA. The label includes storage instructions, dosage note, NDC 43817-422-01, and inactive ingredients listing.*
FDA Label Image

Image00005

Image00005
Tacrolimus Capsules USP, 5 mg oral gelatin coated capsules, labeled for 100 capsules per container. The label includes storage instructions, dispensing information, and manufacturer details for Panacea Biotec Pharma Limited, India, with distribution by Bionpharma Inc., USA. The NDC number 43817-423-01 is visible.*
FDA Label Image

Structure0001

Structure0001
Chemical structure of tacrolimus, showing the detailed molecular arrangement of atoms and bonds typical of this immunosuppressant compound used in oral capsule form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.